Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (20)

2021

  1. Amino-Cupric-Silver (A-Cu-Ag) Staining to Detect Neuronal Degeneration in the Mouse Brain: The de Olmos Technique

    Neuromethods (Humana Press Inc.), pp. 3-19

  2. Behavioral sensitization and cellular responses to psychostimulants are reduced in D2R knockout mice

    Addiction Biology, Vol. 26, Núm. 1

2020

  1. Modeling Parkinson’s Disease With the Alpha-Synuclein Protein

    Frontiers in Pharmacology, Vol. 11

2018

  1. Striatal Reinnervation Process after Acute Methamphetamine-Induced Dopaminergic Degeneration in Mice

    Neurotoxicity Research, Vol. 34, Núm. 3, pp. 627-639

2017

  1. Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms

    Progress in Neurobiology, Vol. 155, pp. 149-170

2016

  1. Fragment C domain of tetanus toxin mitigates methamphetamine neurotoxicity and its motor consequences in mice

    International Journal of Neuropsychopharmacology, Vol. 19, Núm. 8, pp. 1-11

2015

  1. Methamphetamine-Induced Toxicity in Indusium Griseum of Mice is Associated with Astro- and Microgliosis

    Neurotoxicity Research, Vol. 27, Núm. 3, pp. 209-216

2014

  1. D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice

    Neurotoxicity Research, Vol. 25, Núm. 1, pp. 100-109

  2. Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining

    Neuropsychopharmacology, Vol. 39, Núm. 5, pp. 1066-1080

  3. Neurotoxicity of methamphetamine

    Handbook of Neurotoxicity (Springer New York), pp. 2207-2230

2013

  1. Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: Implications for the pathogenesis of free radical-induced neurodegenerative disorders

    Psychopharmacology, Vol. 230, Núm. 1, pp. 125-135

  2. Methamphetamine and parkinson's disease

    Parkinson's Disease

  3. Neurobiology of Methamphetamine

    Biological Research on Addiction (Elsevier Inc.), pp. 579-591

  4. Neurobiology of Methamphetamine

    Biological Research on Addiction: Comprehensive Addictive Behaviors and Disorders (Elsevier), pp. 579-591

  5. The role of dopamine receptors in the neurotoxicity of methamphetamine

    Journal of Internal Medicine, Vol. 273, Núm. 5, pp. 437-453

2012

  1. Dopamine D 1 receptor deletion strongly reduces neurotoxic effects of methamphetamine

    Neurobiology of Disease, Vol. 45, Núm. 2, pp. 810-820

2011

  1. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA

    Neurobiology of Disease, Vol. 42, Núm. 3, pp. 391-403

2010

  1. Genetic inactivation of Pleiotrophin triggers amphetamine-induced cell loss in the substantia nigra and enhances amphetamine neurotoxicity in the striatum

    Neuroscience, Vol. 170, Núm. 1, pp. 308-316

2008

  1. Early loss of dopaminergic terminals in striosomes after MDMA administration to mice

    Synapse, Vol. 62, Núm. 1, pp. 80-84

  2. Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice

    Journal of Neurochemistry, Vol. 107, Núm. 4, pp. 1102-1112